miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

Platinum drugs are used in first-line to treat ovarian cancer, but the most of patients eventually develop resistance to these drugs. Although both c-Myc and EZH2 have been implicated in the regulation of cisplatin resistance in ovarian cancer, the interplay between these two regulators is poorly un...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncogene
Egile Nagusiak: Sun, Jin, Cai, Xin, Yung, Mingo MH, Zhou, Wei, Li, Jing, Zhang, Yi, Li, Zhuqing, Liu, Stephanie S, Cheung, Annie NY, Ngan, Hextan YS, Li, Yiliang, Dai, Zhijun, Kai, Yan, Tzatsos, Alexandros, Peng, Weiqun, Chan, David W., Zhu, Wenge
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474467/
https://ncbi.nlm.nih.gov/pubmed/30166592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0459-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak